[Finished Printing? - Click Here to Return to Normal View]


NIDA Home > Researchers and Health Professionals > Past Meetings Summaries > Drug Abuse and Suicidal Behavior Workshop   

Drug Abuse and Suicidal Behavior Workshop - Agenda



NIDA/UR Center for the Study and Prevention of Suicide
Drug Abuse and Suicidal Behavior Workshop
Bethesda Marriott, Pooks Hill Road


Agenda

March 27, 2003 - Day 1

8:30-8:45 a.m. Opening Remarks and Introductions---Lynda Erinoff, Ph.D., Wilson Compton, M.D., M.P.E., Eric Caine, M.D.
8:45-10:30 a.m. Session 1 - Epidemiology
8:45-9:10 Risk for Suicide Associated With Drug Use Disorders - Kenneth Conner, Psy.D., M.P.H.
9:10-9:35 Prevalence of Suicidal Behavior in Drug-Dependent Inpatients - Jamie Wines, M.D.
9:35-10:00 Suicide and Suicidal Behavior in Viet Nam Veterans - Rumi Price, Ph.D.
10:00-10:30 Discussion - Alec Roy, M.D.
Identifying Gaps, Challenges, and Research Opportunities
10:45-12:30 p.m. Session 2 - Development
10:45-11:10 Behavior Dyscontrol and Self-Regulation - Ralph Tarter, Ph.D.
11:10-11:35 The Development of Suicide Ideation & Attempts: An Epidemiologic Study of First Graders Followed Into Adulthood - Holly Wilcox, Ph.D.
11:35-12:00 Challenges in Conceptualizing and Assessing Suicidal Behavior in Adolescents With Drug Use Disorders - David Goldston, Ph.D.
12:00-12:30 Discussion - Kenneth Sher, Ph.D.
Identifying Gaps, Challenges, and Research Opportunities
12:30-1:45 p.m. Lunch
1:45-3:30 p.m. Session 3 - Comorbidity and Treatment - Depression and Personality Disorders
1:45-2:10 Axis I/II Disorders as Predictors of Prospective Suicide Attempts: Findings from the Collaborative Longitudinal Personality Disorders Study - Shirley Yen, Ph.D.
2:10-2:35 Treatment of Parasuicidal Behavior in Drug-Dependent Women With Borderline Personality Disorder - Marsha Linehan, Ph.D.
2:35-3:00 Cognitive Therapy for Suicide Attempts in Urban, Drug-Dependent Individuals - Greg Brown, Ph.D.
3:00-3:30 Discussion - Richard Ries, M.D.
Identifying Gaps, Challenges, and Research Opportunities
3:30-3:45 p.m. Break
3:45-5:00 p.m. Session 4 - Prevention
3:45-4:10 Prevention in Youth - Elaine Thompson, Ph.D.
4:10-4:35 Suicide Prevention in the Middle Years - Eric Caine, M.D.
4:35-5:00 Discussion - James Anthony, Ph.D.
Identifying Gaps, Challenges, and Research Opportunities

March 28, 2003 - Day 2

8:45-10:15 a.m. Session 5 - Neurobiology/Genetics
8:45-9:10 Genetics of Suicidal Behavior - Anne Glowinski, M.D., M.P.E.
9:10-9:35 Animal Models of Impulsivity and Aggression - Klaus Miczek Ph.D.
9:35-10:00 Human Laboratory Measures of Impulsivity - Donald Dougherty Ph.D.
10:00-10:45 Discussion - J.J. Mann, M.D.
Identifying Gaps, Challenges, and Research Opportunities
10:45-11:00 a.m. Break
11:00-12:15 p.m. Session 6 - Open Discussion (Focused on Integration and Future Directions)
Discussion - Led by Eric Caine, M.D. and James Anthony, Ph.D.
12:15-12:30 p.m. Closing Remarks - Eric Caine, M.D., Sander Genser, M.D., and Lynda Erinoff, Ph.D.


What's New Contents




NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Tuesday, July 22, 2008. The U.S. government's official web portal